Gene Therapy for Sickle Cell Disease: The 2026 Pediatric Milestone
In 2026, gene therapy for sickle cell disease reached a new milestone as the FDA expanded approval to children as young as 2. This article breaks down how the leading therapies work, their safety profiles, cost barriers, and the next wave of treatments poised to reshape access worldwide.
Medical Devices 3D Printing: Industry Landscape & Strategy 2026
Medical devices 3D printing has evolved from a prototyping tool into a regulated production technology reshaping healthcare manufacturing. With the global market valued at up to $5.6 billion in 2026 and projected to reach $24.7 billion by 2034, the stakes have never been higher. This industry-level analysis covers market dynamics, technology, regulation, and competitive strategy for executives and investors.